Stem- cell research ethics revision urged

University of California-San Francisco scientists are urging a revision of stem-cell research ethics in advance of using the procedure to treat disease.

Writing in the current on-line issue of the journal Stem Cells, members of UCSF's Campus Advisory Committee on Human Gamete, Embryo and Stem-Cell Research say current practices must be amended to promote both the safety and well-being of patients who participate in clinical trials and the confidentiality of people who donate the embryos, oocytes and sperm that contribute to the development of embryonic stem cells.

The first author of the paper, Dr. Bernard Lo, a UCSF professor of medicine and director of the UCSF Program in Medical Ethics, wrote: "Lack of attention to these concerns could lead to delays of clinical trials in some cases and inappropriate clinical practices in others. Such developments, in turn, could undermine or delay progress toward stem-cell therapies."

The recommendations are aimed at ensuring the safety of donated biological materials, protecting the privacy of donors, and promoting effective communication between clinician-researchers and patients about the nature of early stage clinical trials.

Copyright 2005 by United Press International


Explore further

Human neural stem cells restore motor function in mice with chronic spinal cord injury

Citation: Stem- cell research ethics revision urged (2005, September 20) retrieved 24 June 2019 from https://phys.org/news/2005-09-stem-cell-ethics-urged.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
0 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more